Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.39 - $5.43 $15,803 - $19,548
3,600 New
3,600 $16,000
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $2.15 Million - $3.15 Million
381,000 Added 635.0%
441,000 $2.99 Million
Q3 2023

Nov 14, 2023

SELL
$6.71 - $11.83 $1.57 Million - $2.77 Million
-234,400 Reduced 79.62%
60,000 $402,000
Q2 2023

Aug 14, 2023

SELL
$11.12 - $22.2 $802,864 - $1.6 Million
-72,200 Reduced 19.69%
294,400 $3.37 Million
Q1 2023

May 15, 2023

BUY
$18.7 - $23.07 $1.71 Million - $2.11 Million
91,600 Added 33.31%
366,600 $7.38 Million
Q4 2022

Feb 14, 2023

BUY
$18.12 - $27.32 $1.9 Million - $2.87 Million
105,000 Added 61.76%
275,000 $6.23 Million
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $10.2 Million - $15.4 Million
-601,100 Reduced 77.95%
170,000 $3.19 Million
Q2 2022

Aug 15, 2022

SELL
$13.15 - $20.45 $7.66 Million - $11.9 Million
-582,500 Reduced 43.03%
771,100 $14.4 Million
Q4 2021

Feb 11, 2022

BUY
$20.24 - $36.01 $505,999 - $900,250
25,000 Added 1.88%
1,353,600 $28.1 Million
Q3 2021

Nov 12, 2021

SELL
$26.01 - $38.22 $101,439 - $149,058
-3,900 Reduced 0.29%
1,328,600 $42.5 Million
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $7.6 Million - $9.43 Million
253,700 Added 23.52%
1,332,500 $41 Million
Q1 2021

May 17, 2021

BUY
$29.24 - $42.03 $27.6 Million - $39.6 Million
942,600 Added 692.07%
1,078,800 $36.3 Million
Q4 2020

Feb 16, 2021

SELL
$35.35 - $50.67 $134,330 - $192,546
-3,800 Reduced 2.71%
136,200 $4.92 Million
Q3 2020

Nov 16, 2020

BUY
$35.98 - $47.66 $2.88 Million - $3.81 Million
80,000 Added 133.33%
140,000 $5.16 Million
Q1 2020

May 15, 2020

SELL
$40.01 - $73.97 $272,068 - $502,996
-6,800 Reduced 10.18%
60,000 $2.85 Million
Q4 2019

Feb 13, 2020

SELL
$37.13 - $74.62 $14.3 Million - $28.8 Million
-385,400 Reduced 85.23%
66,800 $4.79 Million
Q3 2019

Nov 14, 2019

SELL
$39.36 - $76.8 $5.85 Million - $11.4 Million
-148,600 Reduced 24.73%
452,200 $17.8 Million
Q2 2019

Aug 13, 2019

BUY
$52.76 - $82.19 $30.6 Million - $47.7 Million
580,800 Added 2904.0%
600,800 $47 Million
Q1 2019

May 14, 2019

BUY
$27.39 - $68.41 $547,800 - $1.37 Million
20,000 New
20,000 $1.19 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.